Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

436266

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects Orkambi to be appraised by NICE.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19234
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of Orkambi (lumacaftor in combination with ivacaftor) for the treatment of cystic fibrosis in people who are homozygous for the F508del mutation. NICE’s anticipated publication date for this guidance is July 2016. Further information is available at:</p><br /><p>www.nice.org.uk/guidance/indevelopment/gid-tag530</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:20:22 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

433830

registered interest
date	01/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccine Damage Payment Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the Vaccine Damage Payment scheme.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	902566
answer	answer is ministerial correction date of answer 07/12/2015 answer text <p>Policy responsibility for the Vaccine Damage Payment Scheme transferred to the Department of Health from the Department for Work and Pensions (DWP) in May 2014 although DWP continues to administer this scheme. The scheme was last revised in 2007 and no assessment of effectiveness has been made since that date.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/12/2015 13:53:40 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy